There are plenty of problems with Medicare, but patient input into pricing is not one of them. One of the comments on the article sums it up nicely: "The infor

There are plenty of problems with Medicare, but patient input into pricing is not one of them. One of the comments on the article sums it up nicely: "The information asymmetry between the doctor and patient is so great that a patient’s judgement about the value of a given treatment is meaningless. Not to mention that people are irrational actors. To go back to my pharmacy example: demand for cosmetic treatments is often less elastic than it is for treatments that will keep a person alive."